eNewsroom for: Genisphere


Genisphere Company Profile

Genisphere LLC is a nanotechnology company providing innovative tools for targeted drug delivery, clinical diagnostics and life science research based on the company’s 3DNA nanoparticle platform. Genisphere's unique, IP-protected, 3DNA® technology has broad applicability to improve the sensitivity in immunoassay and nucleic acid detection platforms, as well as to deliver therapeutics in a highly specific manner. Genisphere has successfully out-licensed several reagent kits to the research market, and provides customized products to improve the limit of detection of high-sensitivity lateral flow point-of-care tests, enabling their commercialization. Genisphere's diagnostic partners have a competitive advantage due to 3DNA’s ability to improve their test’s sensitivity, with minimal additional costs and no alterations to end-user protocols. For targeted therapeutics, Genisphere provides a fully customizable all-DNA drug delivery platform. Genisphere's robust nanocarrier delivers small drug, RNAi and gene construct therapeutics with greatly improved efficacy and reduced toxicity. The company is continuing to seek partnerships with biotechnology and pharmaceutical companies that could benefit from Genisphere's platform technology

News from Genisphere:

Genisphere's 3DNA® Drug Delivery Platform Achieves Success in Preclinical Treatment of Posterior Capsular Opacification (PCO)

HATFIELD, Pa., March 26, 2015 /PRNewswire/ — Genisphere LLC, provider of the 3DNA® nanotechnology platform, reported today it has achieved specific immunodepletion of problematic Myo/Nog cells implicated in posterior capsular opacification (PCO), a clouding of the eye lens which can be…

Genisphere Awarded Patent for Whole Transcriptome Next Generation Sequencing

HATFIELD, Pa., Feb. 10, 2014 /PRNewswire/ — Genisphere LLC reported today it has been granted a US patent for a novel strand-specific library preparation method for next generation sequencing based on its proven RNA amplification technology. The new patented process enables amplification…

Genisphere Develops a Universal Signal Amplification Process for Lateral Flow Rapid Test Applications

HATFIELD, Pa., Oct. 7, 2013 /PRNewswire/ — Genisphere LLC reported today it has adapted its 3DNA® Nanotechnology for use as a universal signal amplification system for improving the sensitivity and overall performance of rapid diagnostic tests and applications. Detailed in a patent a…